new contraindications for dolasetron (Anzemet)

Canadian authorities are warning of new contraindications for dolasetron (Anzemet).

Dolasetron is approved for the prevention of nausea and vomiting associated with cancer chemotherapy in adults.

But it's often used off-label in children and to treat post-op nausea and vomiting in adults.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote